Toronto-based Biovail Corp. has agreed to pay $10 million to settle a civil lawsuit filed in a federal court in Manhattan by the Securities and Exchange Commission, but did not admit the claims of accounting fraud and investor deception. Four of the company's present and past officers are contesting the SEC's charges. The officers are facing similar allegations filed by the Ontario Securities Commission.

Related Summaries